priority review

Pharma

Takeda's dengue vaccine gets moved up in the FDA review queue

Takeda's dengue fever vaccine, Qdenga, has received priority review from the FDA for its biologics license application.
Kevin Dunleavy Nov 23, 2022 10:30am

Seagen's Tukysa picks up FDA priority review in Herceptin combo

Sep 20, 2022 10:59am

Evrysdi nabs speedy review in SMA patients younger than 2 months

Jan 25, 2022 10:00am

BMS' Orencia snagged priority review in transplant rejection

Aug 23, 2021 11:02am

Seagen and Astellas' Padcev wins an early label expansion

Jul 9, 2021 3:04pm

J&J's multiple myeloma CAR-T scores FDA priority review

May 28, 2021 8:33am